Cargando…

Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment

BACKGROUND: Epithelial lacrimal gland tumours are uncommon orbital tumours and are not widely reported among African populations. OBJECTIVE: This study aimed to describe the clinicopathological features, treatment, and outcomes of epithelial lacrimal gland tumours in Nigeria. DESIGN: Retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasina, Oluyemi, Adeoye, Adewunmi Oluseye, Aremu, Olanipekun Olalekan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089805/
https://www.ncbi.nlm.nih.gov/pubmed/35558566
http://dx.doi.org/10.4103/jwas.jwas_33_21
_version_ 1784704592290775040
author Fasina, Oluyemi
Adeoye, Adewunmi Oluseye
Aremu, Olanipekun Olalekan
author_facet Fasina, Oluyemi
Adeoye, Adewunmi Oluseye
Aremu, Olanipekun Olalekan
author_sort Fasina, Oluyemi
collection PubMed
description BACKGROUND: Epithelial lacrimal gland tumours are uncommon orbital tumours and are not widely reported among African populations. OBJECTIVE: This study aimed to describe the clinicopathological features, treatment, and outcomes of epithelial lacrimal gland tumours in Nigeria. DESIGN: Retrospective case series. SETTING: Ocular Oncology Unit, Ophthalmology Department and Pathology Department of University College Hospital, Ibadan, Nigeria. MATERIALS AND METHODS: A review of the medical records of all patients with histopathological diagnoses of epithelial lacrimal gland tumours managed at a tertiary health facility, southwestern Nigeria over 11.5 years was carried out. RESULTS: Eighteen patients with equal numbers of men and women, and mean age at presentation of 42.2 ± 15.7 years (median 42 years, range 17–70 years) were managed. All patients presented with orbital swelling and had nonaxial proptosis with palpable firm to hard mass in the superotemporal quadrant of the orbit. The mean duration of symptoms was 42.2 ± 38.6 months (median 24 months, range 3–120 months). Visual acuity was <3/60 at presentation in eight (44.4%) of the affected eyes. Thirteen (72.2%) patients underwent orbitotomy and tumour excision, while five (27.8%) patients had orbital exenteration, and two of whom (11.1%) had combined orbital exenteration and craniotomy. Histopathological examination of the specimens revealed pleomorphic adenoma in nine (50.0%) patients, low-grade mucoepidermoid carcinoma in three (16.7%) patients, high-grade mucoepidermoid carcinoma in two (11.1%) patients, adenoid cystic carcinoma in three (16.7%) patients, and adenocarcinoma “not otherwise specified” in one (5.6%) patient. Mortality was reported in four (44.4%) of nine patients with malignant tumours, while no mortality was noted in the patients with benign pleomorphic adenoma. The mean follow-up period for the patients was 28.9 months (median, 4.5 months; range, 2–140 months). CONCLUSION: The main presenting symptom of epithelial lacrimal gland tumours in our patients was an orbital mass and the most common clinical finding, in addition to the orbital mass, was nonaxial proptosis. The tumours were equally divided into benign and malignant lesions in our studied population. Pleomorphic adenoma was the only benign tumour while mucoepidermoid carcinoma was the commonest malignant lesion. Orbital exenteration was performed in a high proportion of our patients and high mortality was noted among patients with malignant tumours.
format Online
Article
Text
id pubmed-9089805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90898052022-05-11 Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment Fasina, Oluyemi Adeoye, Adewunmi Oluseye Aremu, Olanipekun Olalekan J West Afr Coll Surg Original Article BACKGROUND: Epithelial lacrimal gland tumours are uncommon orbital tumours and are not widely reported among African populations. OBJECTIVE: This study aimed to describe the clinicopathological features, treatment, and outcomes of epithelial lacrimal gland tumours in Nigeria. DESIGN: Retrospective case series. SETTING: Ocular Oncology Unit, Ophthalmology Department and Pathology Department of University College Hospital, Ibadan, Nigeria. MATERIALS AND METHODS: A review of the medical records of all patients with histopathological diagnoses of epithelial lacrimal gland tumours managed at a tertiary health facility, southwestern Nigeria over 11.5 years was carried out. RESULTS: Eighteen patients with equal numbers of men and women, and mean age at presentation of 42.2 ± 15.7 years (median 42 years, range 17–70 years) were managed. All patients presented with orbital swelling and had nonaxial proptosis with palpable firm to hard mass in the superotemporal quadrant of the orbit. The mean duration of symptoms was 42.2 ± 38.6 months (median 24 months, range 3–120 months). Visual acuity was <3/60 at presentation in eight (44.4%) of the affected eyes. Thirteen (72.2%) patients underwent orbitotomy and tumour excision, while five (27.8%) patients had orbital exenteration, and two of whom (11.1%) had combined orbital exenteration and craniotomy. Histopathological examination of the specimens revealed pleomorphic adenoma in nine (50.0%) patients, low-grade mucoepidermoid carcinoma in three (16.7%) patients, high-grade mucoepidermoid carcinoma in two (11.1%) patients, adenoid cystic carcinoma in three (16.7%) patients, and adenocarcinoma “not otherwise specified” in one (5.6%) patient. Mortality was reported in four (44.4%) of nine patients with malignant tumours, while no mortality was noted in the patients with benign pleomorphic adenoma. The mean follow-up period for the patients was 28.9 months (median, 4.5 months; range, 2–140 months). CONCLUSION: The main presenting symptom of epithelial lacrimal gland tumours in our patients was an orbital mass and the most common clinical finding, in addition to the orbital mass, was nonaxial proptosis. The tumours were equally divided into benign and malignant lesions in our studied population. Pleomorphic adenoma was the only benign tumour while mucoepidermoid carcinoma was the commonest malignant lesion. Orbital exenteration was performed in a high proportion of our patients and high mortality was noted among patients with malignant tumours. Wolters Kluwer - Medknow 2020 2022-03-26 /pmc/articles/PMC9089805/ /pubmed/35558566 http://dx.doi.org/10.4103/jwas.jwas_33_21 Text en Copyright: © 2022 Journal of West African College of Surgeons https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Fasina, Oluyemi
Adeoye, Adewunmi Oluseye
Aremu, Olanipekun Olalekan
Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title_full Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title_fullStr Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title_full_unstemmed Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title_short Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment
title_sort epithelial lacrimal gland tumours in nigeria: clinicopathological features and treatment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089805/
https://www.ncbi.nlm.nih.gov/pubmed/35558566
http://dx.doi.org/10.4103/jwas.jwas_33_21
work_keys_str_mv AT fasinaoluyemi epitheliallacrimalglandtumoursinnigeriaclinicopathologicalfeaturesandtreatment
AT adeoyeadewunmioluseye epitheliallacrimalglandtumoursinnigeriaclinicopathologicalfeaturesandtreatment
AT aremuolanipekunolalekan epitheliallacrimalglandtumoursinnigeriaclinicopathologicalfeaturesandtreatment